Celltrion’s European filing for CT-P55 advances its bid to enter a fast-growing Cosentyx market, while streamlined trials and limited Western competition could strengthen its commercial position.
Celltrion’s European filing for CT-P55 advances its bid to enter a fast-growing Cosentyx market, while streamlined trials and limited Western competition could strengthen its commercial position.